FDA authorizes updated COVID-19 booster shots targeting omicron variant
Coronavirus,FDA,Coronavirus Vaccine,Booster Shots,CDC,Pfizer,Moderna,BioNTech,BA.5 Variant,Omicron Variant
The U.S. Food and Drug Administration (FDA) announced Wednesday that it has authorized updated coronavirus booster shots targeting the highly-contagious omicron variant.
"Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination," it said in a statement.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
Commentators From Left and Right Preemptively Blame 'Other Side' for Lawfare
November 16th, 2026
Headline Roundup
Could There Be More Behind Jensen Huang's Resignation Than Extramarital Affairs?
November 15th, 2026
Recommended Reading
When Democrats Have To Decide
Dan Schnur
November 16th, 2026